2025 annual financial data
PTC Therapeutics 2025 Operating margin
PTC Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was 49.49%.
Operating income was 856,508,000 USD and net income was 682,644,000 USD.
Operating cash flow was 711,196,000 USD.
Get free PTC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,730,655,000 USD
- Operating income
- 856,508,000 USD
- Net income
- 682,644,000 USD
- Operating cash flow
- 711,196,000 USD